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Abstract: Carbon nanotubes (CNTs) have recently been in the limelight for their potential role 
in disease diagnostics and therapeutics, as well as in tissue engineering. Before these medical 
applications can be realized, there is a need to address issues like opsonization, phagocytosis by 
macrophages, and sequestration to the liver and spleen for eventual elimination from the body; 
along with equally important issues such as aqueous solubility, dispersion, biocompatibility, and 
biofunctionalization. CNTs have not been shown to be able to evade such biological obstacles, 
which include their nonspecific attachments to cells and other biological components in the 
bloodstream, before reaching target tissues and cells in vivo. This will eventually determine 
their longevity in circulation and clearance rate from the body. This review article discusses 
the current status, challenges, practical strategies, and implementations of coating CNTs with 
biocompatible and opsonin-resistant moieties, rendering CNTs transparent to opsonins and 
deceiving the innate immune response to make believe that the CNTs are not foreign. A holistic 
approach to the development of such “stealth” CNTs is presented, which encompasses not only 
several biophysicochemical factors that are not limited to surface treatment of CNTs, but also 
extraneous biological factors such as the protein corona formation that inevitably controls the 
in vivo fate of the particles. This review also discusses the present and potential applications, 
along with the future directions, of CNTs and their hybrid-based nanotheranostic agents for 
multiplex, multimodal molecular imaging and therapy, as well as in other applications, such as 
drug delivery and tissue engineering.
Keywords: opsonins, macrophage, in vivo biocompatibility, near-infrared contrast nanoagents, 
nanotheranostics, nanomedicine
Introduction
The last decade has seen the emergence of a new field of medicine, aptly termed 
“nanomedicine”, which utilizes nanoparticles (NPs) and similar materials to diag-
nose and treat afflictions of the human body. It is logical that an intravenous route 
will be the preferential mode of administering the NPs. Also, given that most end 
capillaries are not more than 5–6 µm in diameter, it can be safely assumed that NPs 
are preferred over microparticles to prevent aggregation and clogging of end vessels. 
The uniqueness of NPs comes from their dimensions (ie, 1–100 nm), which are larger 
than atoms and smaller than cells.1 This allows for engineered NPs to be designed in 
such a way that they tag specific cells, such as tumor cells, and enable monitoring and 
destruction of the respective cell type. Innovative approaches have been proposed to 
design and construct NPs and their architectures with desirable size, shape and func-
tionality, including those based on the programmable self-assembly approach.2,3 Such 





specificity and precision in targeting individual cells is an 
encouraging departure from drugs that systemically target 
cells (even normal cells), leading to undesired side effects.4 
Furthermore, the availability of many unique NPs with their 
characteristic physical, chemical, and optical properties, such 
as photostable fluorescence, multiple conjugation sites for 
ligands, and tunable optical responsiveness to ultraviolet, near 
infrared (NIR), and infrared radiations, etc, is advantageous 
for developing highly versatile targeting platforms.2,3,5,6
Research groups that have been interested in the biomedi-
cal applications of these NPs have the luxury to choose from 
these signature properties to suit their individual needs, and to 
tune the NPs accordingly for their desired effects. One of the 
nanomaterials that attracted our attention was carbon nano-
tubes (CNTs), particularly single-walled CNTs (SWNTs), 
which was prompted mainly due to recent revelations about 
three vital traits that are required for in vivo therapeutic and 
diagnostic (theranostic) purposes. One, even though there 
have been mixed reports about the toxicity of CNTs, intra-
venous injection of adequately processed formulations in 
animal models has yielded encouraging results  concerning 
their biocompatibility;7–13 and CNTs have demonstrated a 
high degree of internalization into a wide range of cells 
that could intracellularly traffic through different cellular 
barriers.14–16 Two, after favorable attachment to ligands, CNTs 
have shown a high degree of specificity to targeted cells and 
tissues.16–19 Three, the high NIR radiation absorption and 
thermal excitability of CNTs, affords minimally invasive 
photothermal (PT) and photoacoustic (PA) detection, as well 
as PT ablation of targeted tissue.2,16 This paved the way for 
integrated nanotechnology-based therapeutics and diagnos-
tics, also popularly known as nanotheranostics, using CNTs 
and their hybrids (such as golden CNTs).2,16,17,20
Despite recent progress, several challenges must be over-
come before CNTs reach their full clinical potential. Particularly, 
issues like opsonization, phagocytosis by macrophages, and 
sequestration to the liver and spleen for eventual elimination 
from the body, should be addressed, which are major obstacles in 
the translation of NPs to clinical practice (Figure 1). This review 
focuses on strategies developed to coat and render CNTs trans-
parent to nonspecific interactions with blood proteins, including 
components of the immune system, in order to improve blood 
circulation times and also to address biocompatibility and 
specific targeting issues, which are vital to the realization of 
their translation into clinical practice. While this review is not 
comprehensive, we discuss the importance of  “stealth”, mean-
ing reduced uptake by the mononuclear phagocyte system, to 
improve the viability of CNTs as future theranostic agents, as 
well as the physicobiochemical properties that govern imparting 
of these traits. Also, we outline and analyze potential strategies 
that are currently being used to impart stealth characteristics to 
CNTs. Finally, we conclude with a discussion on the current 
needs and future directions of this research area.
Challenges and opportunities
Nanotubes as theranostic agents
CNTs are hollow cylindrical tubes with high aspect ratios 
corresponding to 100–300 nm in length for processed CNTs 
and up to 2–5 µm for unprocessed CNTs, and diameters 
of 1–50 nm, depending on the types of CNTs. There are 
currently three known types of CNTs based on the number 
of rolled layers of graphene: SWNTs with a single layer 
(0.8–1.2 nm wide); double-walled CNTs (DWNTs) with two 
layers (1–2 nm wide); and multi-walled CNTs (MWNTs) with 
multiple concentric layers (5–50 nm wide). Ever since their 
discovery in 1991,21 CNTs have attracted a lot of attention due 
to their unique structure and properties. They are known to be 
one of the most versatile nanomaterials around, as they exhibit 
superlative electronic, electrical, optical, thermal, magnetic, 
mechanical and, recently, biological properties.16,22 We will 
focus on the optical, thermal, and biological properties of 
CNTs since they are pertinent to the successful design and 
implementation of in vivo nanotheranostic agents. SWNTs 
exhibit band-gap fluorescence in the 800–1,600 nm wave-
lengths of the NIR spectrum.6 Photoexcitability of SWNTs in 
the NIR range is of extreme significance for biological appli-
cations, since living cells and tissues are virtually transparent 
to NIR radiation in the range of 750–1,200 nm.16,23 Hence, the 
NIR responsiveness of SWNTs makes them ideal candidates 
for bioimaging and in vivo NIR laser targeting. Besides their 
ability to absorb and fluoresce NIR radiation, SWNTs act as 
perfect heat accumulators, where they confine the generated 
heat in its clusters, reducing heat loss to the surroundings.16,24 
This critical property of SWNTs can eventually help in reduc-
ing extensive damage to the surrounding normal tissues by 
localizing the heat to small pockets around itself.16,20 SWNTs 
also have a high melting point of approximately 1,366 K, 
which would ensure a negligible loss of structural integrity 
during the PT nanotheranostics. The combined optical and 
thermal properties have encouraged us to perform experiments 
on bacterial and mammalian cells in vitro, accompanied by 
PT and PA monitoring and PT damage using neodymium-
doped yttrium aluminum garnet (Nd:Yag) infrared laser 
pulses.2,16,20,24–27 The results demonstrated the viable use of 
SWNTs as not only effective targeting agents, but also as 
high-affinity biomolecular interactive agents.





In addition, SWNTs possess the ability to passively 
transport themselves spontaneously through the cell mem-
brane of animal cells, as was recently shown in some in vitro 
studies.14–16 This is dependent on the type, dimensions, and 
nature of the CNT construction.28,29 Henceforth, SWNTs 
have been demonstrated to act as transfection agents to 
transport deoxyribonucleic acid (DNA), ribonucleic acid, 
and other small biological moieties inside cells.17,30 The abil-
ity of SWNTs to interface with many of the biopolymers, 
as well as living cells on the whole, has prompted a wide 
array of biomedical experiments.17,19,20,24–27,31–34 The most 
important reason behind using CNTs as an in vivo vector 
is their shape and structure. The rod-shaped CNT with its 
high aspect ratio (ratio of length and diameter) provides an 
ample surface area for interacting with cell surfaces, while 
also affording favorable conformation to the attachment of 
ligands in multiple ways (Figure 2). For example, in oxidized 
SWNTs, their ends/tips with carboxyl groups (COOH) can 
be used to attach certain ligands with favorable functional 



















Figure 1 In vivo clearance pathway of CNTs after binding to opsonins and after subsequent recognition by macrophages in the blood vessels.
Notes: The macrophages engulf the CNTs and sequester them to the hepato–biliary organs, such as the liver and spleen, for excretion. Processed short CNTs with 
favorable dimension, orientation, charge, and functionalization are eliminated through the renal excretory system.
Abbreviation: CNTs, carbon nanotubes.





used to attach ligands with continuous conjugated systems 
for π-π interactions. This allows for multifunctionalities and 
for a myriad ways to design applications where such traits 
are highly required.
Nanotube biofunctionalization
The architecture and surface chemistry of CNT allows 
for ligands to be attached in four different ways: covalent 
bonding; noncovalent hydrophobic attraction; noncova-
lent π-π stacking; and noncovalent electrostatic attraction 
(Figure 2).35 The covalent bonding of ligands to CNT is 
performed using the carboxyl functional groups that are intro-
duced during the processing of pristine CNT, as a result of 
acid-induced oxidation.36,37 The COOH groups on the CNT’s 
surface can be used to form amide linkages with ligands 
possessing amino groups. However, in some applications, 
this chemical coupling is not favored due to the purported 
effect of disrupting the electronic property of the CNT, and 
also due to the indeterminate number of COOH groups that 
can be introduced on the CNT, which is highly random and 
difficult to control. A given CNT can have COOH groups 
introduced on its entire surface, only partially, or on the tips, 
which could interfere with downstream control of ligand 
attachment, potentially leading to non-uniform distribution. 
For any particle that is chosen for an in vivo theranostic 
application, we believe it is imperative that the coating of 
ligand on its surface has to be complete and uniform, so that 
the actual surface of the particle that will come in contact 
with the surrounding fluids can be minimal and prevent non-
specific protein adsorption – otherwise known as a protein 
corona (Figure 3).
Prevention of protein corona formation is a prerequisite 
for efficient transportation, improved blood circulation half-
life, and biodistribution of the particle. Noncovalent func-
tionalization usually refers to coating the CNT with polymers 
and macromolecules such as polysaccharides, whole proteins, 
nucleic acids, and lipids including a combination of poly-
mers and macromolecules as in 1,2-distearoyl-sn-glycero-
3-phosphoethanolamine-N-[amino(polyethylene glycol)] 
conjugates (Figure 4). This strategy preserves the structural 
Non-covalent functionalization of CNT







Figure 2 Modes of CNT functionalizations.
Notes: (A) Noncovalent functionalizations on the CNT surface are commonly achieved through hydrophobic and π-stacking interactions. (B) Covalent functionalizations 
are commonly performed using 1,3-dipolar cycloaddition and oxidation by acids.
Abbreviation: CNT, carbon nanotube.





and electronic integrity of the CNT by associating with the 
CNT surface indirectly through hydrophobic interactions. 
Noncovalent hydrophobic attraction is possible between the 
hydrophobic sidewalls of the CNT and hydrophobic domains 
located in the ligands.25,38–41 For example, in proteins, there 
are many core hydrophobic domains, which unfold and 
interact with other hydrophobic materials. Polysaccharides, 
such as starch, have been shown to wrap on the CNT surface 
through hydrophobic interactions.40 The iodine molecule in 
the starch–iodine complex undergoes displacement by the 
CNT, thereby enabling the hydrophobic domains of starch to 
interact with the hydrophobic sidewall of the CNT. Another 
example of a hydrophobic interaction is the adsorption of 
phospholipid (PL)–polyethylene glycol (PEG) moieties to 
CNT.42 The two hydrocarbon chains adsorb on the CNT 
sidewall, and the hydrophilic PEG groups render the CNT 
water soluble and biocompatible. However, noncovalent 
 functionalization of CNT is prone to competitive adsorption 
and desorption in a rich medium, such as blood, due to the 
weak and transient nature of the interaction at physiological 
temperatures. This can easily negate the effect of the func-
tional groups on CNT, as the “naked” CNT is now suscep-
tible to tagging for elimination through nonspecific protein 
adsorption in the blood.
Aromatic compounds, due to their unique structure, pos-
sess π electrons that complement the π electron lattice of the 
CNT. This results in π-π stacking of the aromatic rings on 
the CNT sidewall without directly coming in contact with 
the surface.43,44 It is CNT’s unique electronic structure that 
makes such versatile bonding possible, owing to the pres-
ence of delocalized π electrons. Pyrene is one such aromatic 
compound with the versatility to attach functional groups at 
one terminal for conjugation with various ligands. It has been 
demonstrated that proteins can be conjugated to CNT through 
an amino group reactive pyrene derivative.43 The same π-π 
stacking mechanism can be used to helically wrap DNA on 
CNT, making them soluble in aqueous solutions, while also 
enabling separation of metallic CNT from semiconducting 
CNT.41 The helical isoalloxazine assembly of a low molecular 
weight (MW) compound, flavin mononucleotide, hydrogen 
bonds with the CNT chirality and helps in improving CNT 
dispersity and aqueous solubility.45 Due to the ease of use 
and control afforded by noncovalent modifications of CNT, 
we have extensively used π-π stacking, as well as hydropho-
bic and electrostatic attraction to conjugate a wide variety 
of compounds, polymers, and biomolecules on the CNT 
sidewall.25,39,44 Another aspect of a noncovalent conjugation 
strategy is the versatility it imparts for downstream theranos-
tic applications such as PT therapy and PA imaging. It has 
been shown that SWNT solubilized using a polymer carrying 
anthracene groups and irradiated with NIR light is able to dis-
sociate the polymer from the surface of the SWNT and cause 
flocculation.46 Similarly, adsorbed species such as the che-
motherapeutic drug, doxorubicin, can be desorbed from the 
SWNT for release into the surrounding medium using pulsed 
NIR light.47 Therefore, polymers and molecules that can be 
adsorbed on the CNT surface through weak bonds, such as 
through π-π stacking and hydrophobic interactions, provide 
an added advantage due to the weak and facile nature of the 
bond. Through this technique, highly precise and controlled 
drug release mechanisms can be achieved with far-reaching 
implications for nanomedicine. At the same time, caution 
should be applied in thoroughly evaluating these conjugates 
for their stability in various solvents and biological mediums 
before using them in biomedical studies.
Soft corona
CNT
Transverse view Longitudinal view
Hard corona
Figure 3 Protein corona formation on the CNT surface as a result of exposure to 
serum proteins.
Notes: A dense and tightly-bound layer known as the hard corona is directly 
formed on the CNT sidewall, and a loosely-bound layer known as the soft corona is 
formed on top of the hard corona.







Figure 4 various hybrid carbon nanotube conjugates that have shown promise for 
in vitro and in vivo systems.





Processed CNTs (ie, CNTs oxidized using acids)  possess 
numerous charged groups on their sidewalls, such as carboxyl 
and sulfonic acid, which can be used to electrostatically bind 
to other charged moieties.36 This is a conjugation scheme 
that requires not only a high degree of control over the com-
pounds used, but also optimization of the buffer solution to 
prevent any cross-interactions with other charged groups in 
the medium, or that are later encountered in the interacting 
milieu.
It is hard to imagine that any other competing NPs 
have such a varied and suitable repertoire of properties for 
biomedical applications. Gold NPs, quantum dots, titanium 
oxide NPs, and so on, have their own pros and cons; however, 
it is CNTs’ right mix of structure, shape, and optical proper-
ties, as well as their behavior in the biological environment 
that make them a frontrunner amongst contemporary NPs for 
suggested biomedical applications. Despite these advantages 
demonstrated by CNTs, they also possess certain inherent 
disadvantages that make them difficult materials to process 
and handle. CNTs have a high propensity to bundle up due 
to the van der Waals attractive forces existing between the 
individual tubes.48 This leads to complex entanglements 
that make them very difficult to disperse in solutions. The 
sp2 chemical bonding and architecture also make them 
hydrophobic, thereby resulting in extremely low solubility 
in aqueous solutions. It is common knowledge that all living 
systems are water-based and, therefore, aqueous solubility 
is a prerequisite for any potential biomedical applicability. 
Converting pristine CNTs, which are manufactured and sup-
plied as a powder form, from an extremely long, bundled, 
and hydrophobic state into a shortened, individual, and 
hydrophilic state will be the first challenge that investigators 
usually face. Even though many strategies have been imple-
mented to render CNTs as hydrophilic (such as treatment with 
surfactants Triton™ X [Sigma-Aldrich, St Louis, MO, USA] 
and sodium dodecyl sulfate), there is a need for unique and 
novel solutions to make the CNTs not only water soluble, 
but also biocompatible. Surfactants are usually considered to 
be toxic to animal cells, as they denature the cell membrane 
and eventually lead to cell disruption.49
Nanotube biocompatibility
While it is important to assess the toxicity of pristine CNTs 
on vital organs and whole animals for understanding the 
potential risks associated with their usage, it is equally impor-
tant to carefully assess the biocompatibility of processed 
and functionalized CNTs. This gains prominence given that 
well-dispersed and functionalized CNTs, which are currently 
used for biomedical applications, could be eventually used 
in  translational studies. A wide array of cell types have been 
used to characterize the cytotoxicity of CNTs, and the data 
have been inconsistent and inconclusive.50–52 This is mainly 
due to the lack of standard and customized techniques avail-
able to assess CNT toxicity.53 For example, use of different 
cell types and diverse doses of CNTs for each study by differ-
ent research groups has only led to a lack of consensus on this 
issue. It has been shown that viability studies of cells incu-
bated with CNTs and assessed using the commonly used MTT 
assay (3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyltetrazolium 
bromide) yielded false positives due to the physical attrac-
tion of SWNTs with MTT–formazan crystals, thereby 
interfering with the viability study.54 However, the use of its 
water-soluble counterpart, WST-1 (2-[4-iodophenyl]-3-[4-
nitrophenyl]-5-[2,4-disulfophenyl]-2H-tetrazolium) yielded 
a more plausible result as no SWNT–salt aggregations were 
observed. Interestingly, use of three-dimensional cell culture 
models have shown no cytotoxicity when both purified as 
well as oxidized SWNTs were used, when compared to two-
dimensional cell cultures.55 Since three-dimensional cultures 
closely represent the in vivo environment, it is assumed that 
the close cell–cell interactions lead to increased population 
viability and, at the same time, these adhesions prevent the 
uninhibited penetration of SWNTs.55 The role of the elec-
tronic structure of CNTs on biocompatibility has also been 
recently investigated. Metallic SWNTs typically have higher 
reactivity than semiconducting SWNTs.56,57 Accordingly, it 
was observed that cytotoxicity of metallic SWNTs was higher 
on bacterial cultures when compared to semiconducting 
SWNTs.58 This is attributable to increased oxidative stress 
in bacteria caused by metallic SWNTs, due to increased 
glutathione activity. The role of the electronic structure of 
CNTs on the cytotoxicity of human cells also needs to be 
investigated, given that new and improved label-free, high-
resolution techniques have emerged that can selectively 
distinguish semiconducting SWNTs from metallic SWNTs 
with submicron accuracy in living systems.59 Besides these 
factors, various parameters, such as CNT surface properties 
and the presence/absence of impurities, also influence cyto-
toxicity studies to a great extent.
Nanotube surface chemistry
Investigators have reported extensively on the adverse effects 
of pristine CNTs on various organs, organ systems, and on 
the general well-being of experimental animals.60–63 In cellulo 
studies also suggested that the rope-like agglomerates of 
unprocessed SWNTs were found to be more cytotoxic than 





well-dispersed walled nanotubes on mesothelioma (MSTO-
211H) cells, even more than asbestos.52 The agglomerates, 
which are micron sized in diameter and length, are known 
to cause inflammatory reactions such as granulomas in the 
reticuloendothelial system (RES) organs such as the lungs, 
liver, and spleen through a process known as “frustrated 
phagocytosis”.62 This occurs when activated macrophages 
unsuccessfully attempt to engulf the large agglomerates and 
proceed to form granulomas – a subtype of chronic inflam-
mation. Therefore, the need for well-dispersed CNTs for bio-
medical applications cannot be more overemphasized. CNTs 
are capable of forming well-dispersed suspensions in aqueous 
solutions after oxidation in acid solutions, mainly due to the 
formation of carboxyl groups.64 Even higher degrees of aque-
ous solubility can be attained by functionalizing the sidewalls 
with hydrophilic moieties, such as polymers. Studies on 
Chinese hamster ovary cells and Jurkat human T-lymphoma 
cells using glycopolymer-coated SWNTs and unfunctional-
ized SWNTs have demonstrated lower cytotoxicity for the 
functionalized SWNTs.65 Also, unfunctionalized SWNTs 
provoked the secretion of proinflammatory cytokines by 
macrophages in comparison to amino group-functionalized 
SWNTs.66 Some earlier studies using covalently conjugated 
streptavidin-SWNTs demonstrated extensive cell death of 
human promyelocytic leukemia HL60 cells after 2 days.67 
In vivo studies using functionalized CNTs have shown good 
biocompatibility and faster clearance rates. The degree of 
chemical functionalization has proven to be the most impor-
tant determinant of toxicity, with the higher degree of surface 
functional groups causing lesser accumulation in the liver 
and faster clearance through the renal system (Figure 5). 
In a study using 99mTc-labeled MWNTs, surface carboxyl 
functional groups with a density of .3 µmol/mg and lengths 
,500 nm of individualized nanotubes have demonstrated 
rapid clearance and low toxicity.8 Interestingly, the nature of 
the functional group, carboxyl or ammonium, was not criti-
cal to the low toxicity exhibited by the highly individualized 
CNT with multiple surface functional groups.13
Nanotube impurities
CNTs synthesized by both the arc–discharge process and 
chemical vapor deposition contain a high degree of catalytic 
impurities such as Fe, Co, and Ni.64 The cytotoxicity of these 
metals is well known and well documented. It was demon-
strated that rat macrophages and human A549 lung cells, 
when exposed to unpurified CNTs, released reactive oxygen 
species intracellularly due to cell oxidative stress.68 Other 
cytotoxic effects include apoptosis; decreased adhesiveness 
and inhibition of proliferation of human embryo kidney cells; 
increased intracellular lipid hydroperoxides and the lowering 
of low MW thiols in murine macrophages; and lower cell 
proliferation rates in human epidermal keratinocytes.69–71 
 However, when highly purified CNTs were incubated with 
3T3 and HeLa cells, no cytotoxicity was observed.72 In 
another study, when A549 cells were separately treated with 
CNTs with 2% and 15% metal residues (predominantly Fe), 
cells demonstrated reduced viability with 15% impurities 
in comparison to those treated with 2% impurities.73 The 
Hepatic clearance Renal clearance
Factors governing hepatocyte versus Kupffer cell uptake and renal clearance:
    - size and shape
    - surface charge










Figure 5 Hepatic and renal cellular ultrastructure illustrating the clearance mechanisms and physicochemical factors that contribute to effective clearance of CNTs.
Notes: Those opsonin-coated CNTs that escaped being phagocytized by macrophages in the blood are eventually recognized and internalized by resident macrophages in 
the liver and Kupffer cells. Depending on certain physicochemical characteristics of CNTs, such as size and surface properties, some CNTs traverse the fenestrae in the 
endothelial layer of the liver sinusoids and enter the hepatocytes for eventual excretion through the hepato–biliary–fecal route. In the kidneys, however, only shortened 
CNTs with favorable charge characteristics and proper alignment can traverse the narrow (ie, 5 nm) pores.
Abbreviation: CNT, carbon nanotube.





most commonly used method to remove the impurities 
involves acid treatment of CNTs to oxidize the catalysts. As 
a result of this procedure, carboxyl and hydroxyl groups are 
introduced on the CNT sidewalls.64 Surprisingly, it has been 
shown that purified CNTs are more cytotoxic when compared 
to unpurified CNTs, as demonstrated on human intestinal 
cells, Caco-2.50 This can be attributed to the carboxyl and 
hydroxyl groups on the CNT surface. It can, therefore, be 
reemphasized that rendering CNTs soluble in aqueous solu-
tions does not guarantee the biocompatibility of the CNTs. 
Hence, it is imperative that further functionalization of the 
CNT surface is needed in order to shield the sidewall from 
the surrounding environment.
Interestingly, impurities such as Fe can be used advan-
tageously for enabling the magnetic resonance imaging 
(MRI) of CNTs. Superparamagnetic iron NPs are known to 
 influence the relaxation time of nuclear magnetization, and 
they have been used extensively as MRI contrast agents. This 
was tested using high-pressure carbon monoxide (HiPCO) 
SWNT with iron oxide NPs attached to one of the nanotube 
tips and wrapped with DNA to assist in dispersion. The 
SWNTs were internalized by macrophages and imaged in 
vitro using MRI.74 In another study, pristine SWNT with 
Fe impurities (10% w/w) was used for studying the in vivo 
biodistribution of systemically injected SWNTs using proton 
MRI imaging. A significantly higher gradient echo signal 
was obtained from the spleen and kidneys for pristine SWNT 
in comparison to purified SWNT.75 It is yet to be seen if 
toxicologically tolerable amounts of impurities in SWNTs, 
such as 2% Fe determined using in vitro assays, could permit 
MRI  imaging. In a following study, it was found that purified 
SWNTs with 2% impurities and functionalized SWNTs with 
0.7% impurities did not yield a statistically appreciable sig-
nals, thus confirming a threshold value of 10% Fe impurities 
required for significant MRI contrast.76 Importantly, this study 
 corroborates that 2% Fe, as impurities, can be tolerated in 
vivo, as no acute toxicological effect was observed in the liver 
using high-resolution magic angle spinning and quantitative 
real-time polymerase chain reaction analysis.
Nanotube biodistribution and biokinetics
Many pharmaceutical companies seek the development of 
novel drug delivery systems to deliver the correct dose at a 
specific site. The failure of traditional therapeutics in deliv-
ering precise and controlled amounts of a drug to targeted 
sites has often led to severe unwanted side effects, mainly 
as a result of administering excessively high doses.4 Novel 
nanomaterials such as CNTs are poised to address this issue 
due to the wide variety of targeting moieties that can be 
functionalized onto their surface. This new modality in thera-
peutics, through precision targeting, is expected to reduce 
systemic side effects and improve clinical outcomes. Usually, 
NP-based therapeutics are reliant on carefully selecting the 
right type of NP, wherein the NP simply serves as a vector 
to carry the therapeutic agent (such as antitumor drugs). To 
cite a few examples, the US Food and Drug  Administration 
has approved some nanoparticulate and microscale drug 
delivery systems: Abraxane® (paclitaxel conjugated to 
albumin particles; Celgene Corporation, Summit, NJ, USA); 
AmBisome (amphotericin B liposome; Astellas Pharma US, 
Inc,  Northbrook, IL, USA); Myocet (doxorubicin  liposome; 
Enzon Pharmaceuticals, Inc, Picastaway, NJ, USA); Elestrin® 
(estradiol complexed to calcium phosphate NPs; Meda 
Pharmaceuticals Inc, Somerset, NJ, USA), and so on.77 The 
common theme in this list of nanoparticulate formulations is 
that almost all of them have the active component (the thera-
peutic agent) as the functionalized conjugate, and the carrier 
serves only for translocating it to the target site. However, 
the uniqueness of CNT stems from the fact that it can serve 
not only as a vector, but also as a theranostic agent due to its 
unique optical and thermal properties.
Generally, good therapeutic and clinical success can be 
achieved if four important parameters can be satisfied: low 
toxicity; increased blood residence time; high  specificity; 
and excretability. From the moment the particle is 
injected intravenously until the moment it is completely 
excreted, it will have to defy the natural homeostasis (it 
is, understandably, an engineered “foreign” material in 
the body) and perform functions autonomously. One has 
to approach the selection and design of the NP with these 
factors in perspective, fully understanding that each phase 
is connected to the other and interdependent on each other’s 
success. Surface functionalization of the CNT will aid in 
improving all four parameters (Figure 4). Besides surface 
functionalization, other parameters such as size and shape 
could also contribute to the “harmonization” of the CNT with 
the internal milieu. The good biodistribution, prolonged cir-
culation time, blood hydrodynamics, and low clearance rate 
of CNT is an essential prerequisite for its proposed biomedi-
cal applications, such as tumor targeting and drug delivery. 
After intravenous injection, the CNT’s blood residence time, 
organ biodistribution, and accumulation and clearance half-
life are highly dependent on its surface characteristics and 
coating (Figure 5).
One of the critical events that occurs immediately 
after NP injection into the bloodstream is the formation 





of a biomolecular corona, also known as protein corona 
(Figure 3). This is the nonspecific interfacial reaction of 
blood proteins on the NP surface, which could play a deci-
sive role in the biodistribution and biokinetics of NPs.78 
Due to their high aspect ratio, CNTs can adsorb a large 
number of proteins on their sidewalls through: a π-π stacking 
interaction between the aromatic residues (for example, Tyr, 
Phe, and Trp) and the SWNT sidewall; electrostatic interac-
tions; and hydrogen bonding.79,80 Proteomic analysis of the 
protein corona derived from human plasma adsorbed on the 
PEGylated SWNT revealed up to 500 proteins, and those 
derived from tissue culture media had up to 366 proteins 
adsorbed on the oxidized SWNT.80,81 However, it is impor-
tant to delineate “hard” coronae (ie, a tightly bound near-
monolayer of biomolecules adjacent to the NP surface) from 
the “soft” coronae (ie, a more loosely associated and rapidly 
exchanging layer of proteins on top of the hard coronae) 
(Figure 3).78 A total of 181 proteins out of 366 constituted 
the hard corona in a study that employed cell culture media.80 
The hard coronae represent not only the biomolecules that 
are the most abundant in the plasma and serum, which come 
in contact with the NP immediately upon introduction to the 
biological environment, but also quite possibly ones with the 
highest affinity to the NP surface. The affinity of the proteins 
to the NP surface is highly fleeting and varies depending 
on the type of surface  coating, density of the coating, and 
charge. For example, it was determined that oxidized and 
charged CNTs (ie, with COOH groups) adsorb more proteins 
than pristine CNT, and the most abundant proteins are titin, 
albumin, and apolipoproteins.80 Proteins, such as comple-
ment factors (C1q), even showed a preference for MWNT 
over SWNT and DWNT, mainly due to their larger dimen-
sion and unique geometry.82 Using HeLa cell lysates, it was 
shown that there is no strong correlation between protein 
affinity to the MWNT and their relative abundance in the 
medium, suggesting selectivity of the MWNT to certain pro-
teins.81 MWNTs behave as protein magnets by attracting and 
accumulating additional proteins, even after their surface is 
completely saturated by a protein corona.82 This phenomenon 
can be attributed to strong protein–protein  interactions. It 
is assumed that PEGylation of the NPs and other formula-
tions prevents nonspecific protein adsorption in vivo. It 
was, however, demonstrated that not only does PEG not 
prevent protein corona formation, the pattern of adsorbed 
proteins also varies with the change in PEG conformation 
(Figure 6).83 When the PEG conformation transitioned from 
mushroom to mushroom–brush, human fibrinogen became 
more abundant than immunoglobulin (Ig)M and IgG on the 
SWNT surface. This further led to shorter blood circulation 
times, higher splenic versus liver accumulation, and faster 
renal clearance. It can be speculated that the quantitative dif-
ferences in the proteins could alter the biodistribution profile. 
For example, higher IgM on SWNT could lead to preferential 
uptake by the liver. Most importantly, protein corona can 
also decrease the toxicity of CNTs by effectively shielding 
the surface from the external milieu.79 In addition, protein 
coronas might play a bigger role in CNT biokinetics in vivo, 
such as assisting in cellular interactions through biomolecular 
recognition, internalization, and signaling processes.84,85
The first biodistribution profiling of SWNT in mice was 
performed by Wang et al,86 where hydroxylated SWNTs 
were shown to be rapidly removed from circulation and 
distributed evenly throughout the body. The blood clear-
ance half-life was 49 minutes.86 Cherukuri et al87 reported 
that SWNTs dispersed using Pluronic® F108 (BASF SE, 
Ludwigshafen, Germany) surfactant had a blood circulation 
half-life of only 1 hour, as most of the SWNTs predomi-
nantly accumulated in the liver.87 Singh et al88 demonstrated 
SWNTs conjugated to a chelating agent, diethylenetriamine-
pentaacetic acid (DTPA), accumulated in kidneys (10.5% 
injected dose [ID]), muscle (6% ID), and skin (2% ID) 30 
minutes post-intravenous injection.88 The blood clearance 
rate was 3.5 hours. Almost similar blood clearance rates 
were observed by McDevitt et al89 on using 1,4,7,10-tetraa




Figure 6 Shielding of the CNT surface using short linear, long linear, and long 
branched polymers and their effect on opsonization.
Notes: Long branched polymers are able to shield the CNT surface more effectively 
due to denser coverage on the CNT surface in comparison to short and long linear 
polymers.
Abbreviation: CNT, carbon nanotube.





potent chelating agent compared to DTPA, conjugated to 
SWNT.89 The DOTA–SWNT conjugate accumulated in the 
kidneys (8.3% ID), liver (17.8% ID), spleen (14.3% ID), 
and bone (2.26% ID) 3 hours post-injection. PEGylation 
of the NPs has been extensively employed to render the 
xenobiotics resistant to opsonins, macrophages, and RES in 
general. Currently, it is the most popular agent to prevent the 
nonspecific adsorption of blood proteins in vivo. Liu et al42 
reported branched PEG–PL with a MW of 2,000, 5,400, and 
7,000 conjugated to SWNTs had varied blood circulation 
and biodistribution profiles.42 As the degree of branching 
increased from a MW of 2,000–7,000, there was an increase 
in the blood circulation half-life from 0.5–7 hours. Raman 
measurement on hepatic sequestration showed a decreasing 
trend: 70% ID/g for 2,000 MW PEG–PL–SWNT and 30% 
for 7,000 MW PEG–PL–SWNT at 24 hours post-injection. 
Therefore, higher degrees of branching of PEG leads to a 
more uniform and complete coating of the SWNT surface, 
which leads to a higher blood circulation half-life and 
delayed clearance (Figure 6). The blood residence time 
of PEG did not continue to demonstrate an upward trend 
beyond 7,000 MW PEG. This clearly demonstrates the need 
to sheath the CNT surface from the external environment by 
ensuring that most of (and if possible, the entire surface) is 
coated with the functionalizing agent. Also, there is a need 
for more coating materials that have PEG-like properties 
to prevent opsonization and RES sequestration. This will 
provide more options for investigators to coat various kinds 
of xenobiotics for in vivo applications.
The dynamics of the CNT in vasculature is essential to 
understand its interaction with the vessel wall, for both specific 
targeting to vascular targets, as well as for the prevention of 
nonspecific binding. The aspect ratio of the CNT is of par-
ticular concern, as there is speculation that it might damage 
the vasculature. This can be a difficult interaction to study in 
vivo. Recently, using synthetic microvascular networks, it was 
shown that polystyrene nanorods demonstrate sevenfold higher 
specific binding to vascular targets when labeled with target-
ing antibodies compared to unlabeled nanorods.90  Conversely, 
only a twofold advantage in specificity was observed with 
the nanospheres. Interestingly, nanorods demonstrated sig-
nificantly lower nonspecific binding to the vessel wall when 
compared to nanospheres. However, the binding to vascular 
walls decreased as physiologically relevant hemodynamic 
shear stress increased. Even though CNTs were not used for 
this study, this has significant implications for all high aspect 
ratio NPs concerning the interplay with their shear dynam-
ics and their interaction with vascular walls in vivo. In vitro 
studies have shown that in the event of nonspecific binding 
to vascular walls, the endothelial cells can transiently uptake 
SWNTs into the acidic vesicles, while not causing any cyto-
toxicity. Eventually, the cells release the nanotubes into the 
extracellular medium within 72 hours.91 The transient uptake 
and subsequent release of the nanotubes into the bloodstream 
bode well for CNT-based theranostics and, hopefully, allay any 
concerns regarding damage to vasculature due to the CNT’s 
high aspect ratio. However, further in vivo studies using real-
time high- resolution imaging techniques, such as intravital 
multiphoton microscopy, would help in better understanding 
this complex interplay. Recently, SWNTs have enabled high 
spatial resolution (30 µm), deeper penetration (1–3 mm), 
and fast acquisition (,200 ms) imaging of vasculature in the 
NIR 2 (1100–1400 nm) window that opens the door for further 
investigations into vascular hemodynamics and interactions 
with CNTs.92 When coupled to transient absorption micros-
copy, submicron resolution imaging can be achieved, which 
would permit investigating real-time nano–bio interactions 
with individual nanotube sensitivity.59
The liver and kidney are the two main organs involved 
in the clearance of xenobiotics, while pulmonary clearance 
cannot be ignored in the case of inhaled particles. In the liver, 
the parenchymal cells (hepatocytes) and phagocytic Kupffer 
cells represent the major pathway for clearance at the cellular 
level (Figure 5). Xenobiotics taken up by hepatocytes are 
eventually eliminated via bile into the feces, whereas those 
taken up by Kupffer cells are retained for a prolonged period 
of time and are enzymatically degraded in the phagolyso-
somal complex. Uptake by the hepatocytes versus Kupffer 
cells is governed by factors such as size of the NP, adsorbed 
opsonins on the NP surface, and charge of the NP. Typically, 
particles larger than 200 nm cannot cross the fenestrations 
of the liver sinusoids that drain into the parenchyma (Fig-
ure 5);93 however, well individualized CNTs could traverse the 
fenestrae oriented along their long axis. It has been reported 
recently that shortened and well individualized CNTs with 
an average length of 200–300 nm pass through the glom-
erular membrane and get excreted through the renal system 
(Figure 5).94,95 This is partly because the glomerular capil-
laries in the kidney predominantly filter based on the size of 
the particles. Charge-based uptake was recently investigated 
using real-time intravital multiphoton microscopy, which 
revealed that negatively charged particles are taken up by 
Kupffer cells, and positively charged particles are taken up 
by hepatocytes.96 This was corroborated using carboxylated 
MWNT in a RAW 264.7 macrophage cell line that showed 
preferential uptake for oxidized MWNTs over PEGylated 





MWNTs.97 Protein corona formation inadvertently affects 
specific binding of the NPs to the numerous receptors present 
on the surface of the Kupffer cells (Figure 5). Since protein 
corona is an inevitable outcome of systemic injection of the 
NPs, it is highly likely that majority of the CNTs localize in 
the Kupffer cells.78
Until a few years back, it was assumed CNTs are nonbio-
degradable and would accumulate and biopersist in organs, 
leading to chronic inflammation and eventually long-term 
toxicity.61,62 Recent evidence points to the possibility of 
addressing this issue through enzymatic degradation of the 
CNT in biological systems, thereby assisting in its elimina-
tion (Figure 7). Phagocytic cells such as macrophages and, 
notably, neutrophils have an abundance of myeloperoxidase 
(MPO), a peroxidase enzyme that generates hypochlorous 
acid and other reactive intermediates that are known to have 
enough oxidizing potential to break C−C and C−H bonds 
(Figure 7).98 Molecular modeling studies have revealed the 
binding of SWNT to the catalytic sites of the enzyme, which 
initiates the hypochlorite-mediated biodegradation of SWNT, 
assisted by other reactive intermediaries.99 Other peroxidases 
such as horseradish peroxidase and heme-dependent per-
oxidase are also capable of effectively degrading CNT.100,101 
However, the effectiveness of degradation has a strong cor-
relation to the abundance of the enzyme in respective cell 
types. For example, MPO-rich neutrophils degraded 100% 
of the SWNTs after 12 hours through the synergistic action 
of MPO and nicotinamide adenine dinucleotide phosphate 
oxidase, whereas macrophages with less abundant MPO 
only degraded 13% of the SWNTs at the end of 12 hours, 
which progressed to a more pronounced 50% after 48 hours 
of incubation.99 An in vivo study on MPO-deficient mice 
revealed that as a result of lower oxidation, the inflamma-
tory response to SWNTs was higher than in the wild-type 
mouse, which led to a lower clearance rate.102 Other phago-
cytic cells, such as brain microglia, have also demonstrated 
partial biodegradation of MWNTs after 14 days of in vivo 
stereotactic administration into the mouse motor cortex.103 
The partially degraded CNT could yet be a cause for concern 
not only due to its long-term proinflammatory potential, but 
also because of the molecular byproducts of the degrada-
tion pathway, such as polyaromatic hydrocarbons. However, 
upon administration of a partially degraded SWNT sample 
into the mouse pulmonary system, there were no signs 
of inflammatory markers in the pharyngeal aspirate.99 In 
contrast, nondegraded SWNTs showed acute inflammatory 
response accompanied by granuloma formation in the lungs. 
The biodegradation of CNTs, while encouraging, should be 
cautiously and thoroughly evaluated in various cell types, 
including the human microbiome, and the effect of the oxi-
dative bimolecular machinery on different types of CNTs 
should be carefully assessed.
In environmentally relevant conditions, CNTs can be 
biodegraded by the cooperative activity of several micro-
organisms, as revealed by a study using 14C-labeled MWNT.104 
Up to 6.8% of MWNT was transformed to 14CO
2
 over a period 
of 7 days with the help of an external carbon source for 
cometabolism. However, CO
2
 was not the only byproduct 
of the degradation pathway, as other intermediaries such as 
2-naphthol, 2-methoxy naphthalene, isophthalic acid, and so 
on, were also generated. Importantly, it was demonstrated 














Figure 7 CNT biodegradation in vivo.
Notes: Circulating neutrophils expressing opsonin-binding receptors, such as Fc and complement receptors, in the blood are capable of internalizing and degrading opsonin-
coated CNTs. Myeloperoxidase, a peroxidase enzyme abundantly expressed in neutrophils, is capable of degrading the lattice structure of CNTs by breaking the C−C and 
C−H bonds.
Abbreviation: CNT, carbon nanotube.





MWNT. When a combination of different microorganisms 
was used, there was a tenfold increase in the biodegradation 
of MWNTs. This has important implications for the environ-
ment in general, as the environmental persistence of CNTs 
can be attenuated. In addition, it holds important implications 
for in vivo applications where the human microbiome could 
play a potential role in assisting further biodegradation of 
CNTs in the gastrointestinal tract and other sites with a size-
able population of microbiota. Degradation is also dependent 
on the type and surface functionalization of the CNT. An in 
vitro study has shown that SWNTs are oxidized and degraded 
more efficiently when compared to MWNTs.105 In addition, 
SWNTs with surface carboxyl groups are degraded efficiently 
when compared to pristine, ozone-treated and aryl-sulfonated 
SWNTs.106 A greater degree of carboxyl functionalization, 
which considerably improves the hydrophilicity of the CNTs, 
leads to an improved rate of degradation.107 Therefore, sur-
face rendering of the CNTs and NPs in general for rapid and 
efficient elimination is an ongoing critical investigation that 
will eventually determine their potential for theranostics and, 
ultimately, clinical translatability.
Need for stealth
The immune system is a defense mechanism of the human 
body that acts against invading pathogens and foreign materi-
als, and works on the basic “self/non-self ”  discriminatory 
rule. Anything considered harmful, including cells of the 
human body, are quickly eliminated. Macrophages are 
decorated with a wide arsenal of receptors hooked to the 
plasma membrane: 1) receptors for complement factor 
C3b; 2) receptors for the Fc portion of immunoglobulins; 
and 3) receptors to mannose/fucose and other bacterial surface 
polysaccharides (Figure 1).108–111 Once the pathogen/ foreign 
material that has already been tagged by opsonins comes in 
contact with macrophages, it is rapidly recognized by the 
receptors, which then initiate the phagocytic process where 
the particle is engulfed by the macrophage for intracellular 
digestion. Any undigested particles end up in the liver and 
spleen and are eventually excreted.112 It can then be safely 
agreed that CNTs would suffer the same fate as any pathogen 
entering the bloodstream (Figure 1). Opsonins, C3b, and IgG, 
which are present in the blood in substantial quantities, will 
readily attach to the hydrophobic sidewall of the CNT, which 
will tag them for macrophage recognition. Even in reports 
where whole-body biodistribution studies are conducted,42,89 
after amenable functionalization with ligands that prolong 
blood residence times, there are high percentages of NPs 
that end up in the liver and spleen because materials injected 
in bulk, in order to improve bioavailability, often aggregate 
and precipitate. In such studies, the only way to effectively 
monitor the location of the particles is to have a high enough 
concentration to be able to trace them. Therefore, a probable 
solution to improve the blood residence time is to devise 
novel ways to coat the CNT with biocompatible ligands, 
which prevents the attachment of opsonins to the CNT by 
acting as a shield, and individually assess their performance 
in vitro and in vivo. By simulating the microenvironment of 
the blood vessel where such events are likely to take place, in 
a matter of 1–4 hours after injection, one can determine the 
behavior and fate of CNT and devise appropriate modifica-
tions to shielding if necessary. Shielding is a crucial step in 
rendering the CNT transparent to opsonins and deceiving the 
innate immune response to make believe it is not foreign. 
The success of any diagnostic or therapeutic precision target-
ing system cannot be taken for granted by overlooking the 
stealth mechanics of the given particle. Acquaintance with 
the  factors and principles that normally decide the stealth 
behavior of a particle is required before we delve into the 
strategies used to coat CNTs.
Physicobiochemical characteristics  
governing stealth nanotube agents
Size matters
Physiological and anatomical parameters, such as blood 
transport, tissue diffusion, hepatic filtration, and renal excre-
tion, along with the size of fenestrae in the end capillaries, 
dictate that the size of the particles is an important factor 
that ensures prolonged circulation times and high therapeutic 
efficacy for NPs.113 It was shown that in polystyrene particles, 
ranging from 50–500 nm, larger particles demonstrated 
higher levels of hepatic sequestration, thereby lowering their 
circulation times.114 Since the emphasis is on how NPs inter-
act with opsonins and macrophages, the radius of curvature, 
which is related to size, will impact protein attachment and 
subsequent macrophage interaction. It has recently been 
shown that the NP size is not as important a determining 
factor for phagocytosis as it was thought to be.115,116 Instead, 
it was found that macrophages recognize NPs as a function 
of the number of opsonins that are attached, rather than the 
function of size.116 A recent study comparing SWNTs and 
titanium dioxide (TiO
2
) NPs revealed that SWNTs adsorbed 
fewer plasma proteins, even though they had a larger surface 
area.117 SWNTs with a diameter of 0.8–1.2 nm are narrower 
than the smallest TiO
2
 NPs (∼2 nm), thus having a high radius 
of curvature, which tends to offer fewer attachment sites for 
plasma proteins than larger particles with a lower radius of 





curvature. Fewer opsonins on narrower particles such as 
SWNTs mean lower uptake by macrophages, which would 
translate to higher SWNT blood circulation times.
Some authors have demonstrated that for particles less than 
100 nm, there is minimal to no uptake by the  macrophages, 
whether they are coated or not by opsonins.118,119 Therefore, 
it can be concluded that for particles with a high radius of 
curvature and a small size (,100 nm), the outcome is more 
promising when compared to larger particles with a low 
radius of curvature. This augurs well for SWNTs, which 
have an effective diameter of 0.8–1.2 nm and lengths that 
vary from 50–150 nm after processing. With such a narrow 
diameter and high radius of curvature, it would seem that 
SWNTs are ideally suited to escape opsonin binding, with-
out any extraneous functionalization and coating. However, 
the length of the SWNT has a propensity to show a lot of 
variation, mainly due to the random nature of the shorten-
ing process employed. In vivo, shorter CNTs have shown 
propensity towards improved biodistribution and effective 
clearance through the kidney and liver.42,94,96 Shorter CNTs 
(,200 nm) are able to traverse the endothelial cell barrier 
through their fenestrae along both axes, which would poten-
tially permit uptake by hepatocytes and excretion through 
feces. However, in kidneys, the physiologic pore diameter 
is significantly smaller (around 5 nm), therefore permitting 
passage of only aligned SWNT, tip first and along the longi-
tudinal axis (Figure 5).
effect of shape
It has been demonstrated that the shape of NPs plays a 
greater role than their size in the process of phagocytosis by 
macrophages. Different shapes of polystyrene particles were 
synthesized and exposed to macrophages after opsonization 
with IgG.115 The Ω-angle was defined as the angle formed 
between the point of contact of the cell membrane and the 
particle. Phagocytosis was not initiated at Ω .45° for non-
spherical particles. Opsonized and nonopsonized particles 
had the same Ω dependence.115 This essentially means that 
particle internalization is primarily dictated by the shape of 
the surface at the point of initial contact. For example, in a 
rod-shaped particle, internalization is initiated only if the 
tip/end of the rod comes in contact with the cell membrane 
of the macrophage, whereas no internalization happens if 
the point of contact is the sidewall. In a recent study,120 it 
was demonstrated that MWNTs undergo tip-first recogni-
tion and entry into cells. Through receptor clustering at 
the rounded tube tips, the cells initiate the uptake of the 
one-dimensional particles. Interestingly, this was observed 
only in tubes that had closed end caps, and not in open-ended 
tubes. Therefore, orientation of the rod prior to interacting 
with macrophage will play a great role in determining if 
internalization proceeds or not. Spherical particles are not 
faced with this complication and, therefore, will more read-
ily undergo internalization. The shape of the SWNT clearly 
affords it an advantage in comparison to spherical and ovoid 
particles as extraneous and additional factors, such as orienta-
tion, do not play any role in their internalization. However, 
the orientation of SWNTs is crucial for in vivo clearance, 
particularly for shortened SWNTs, when in the glomerulus, 
as the small functional pore size of the endothelium-basement 
membrane–podocyte complex will only permit passage if the 
orientation is along the long axis (Figure 5).94,95
Surface hydrophilicity
Hydrophilicity, when compared to hydrophobicity, is known 
to greatly prevent nonspecific adsorption.121 Opsonins, IgG 
and complement factors, and plasma proteins in general 
adsorb more readily on hydrophobic surfaces than on hydro-
philic surfaces (Figure 3).122–124 In vitro and in vivo studies 
have also demonstrated higher degrees of phagocytosis and 
increased sequestration to hepatic tissue of hydrophobic 
particles in comparison to hydrophilic particles.123,125–127 In 
order to counteract the attractive hydrophobic forces between 
the hydrophobic particle and proteins, polymers such as PEG 
are conjugated to hydrophobic surfaces.128 PEG, along with 
other similar polymers, are hydrophilic, inert (no net charge), 
biocompatible, and elicit no response from plasma proteins.128 
The presence of the polymer coating on hydrophobic surfaces 
creates a water cloud, which serves as a potential barrier 
against plasma proteins by preventing any binding from 
occurring, while denying any attachment sites.129 The water 
cloud is formed due to the high affinity and linking of two 
to three water molecules by each polymer chain.130 The low 
attractive forces between the surface and proteins are due to 
the creation of minimum interfacial free energy by the water 
cloud.129 Besides polymers such as PEG, polysaccharides are 
also used, mainly due to their biodegradability.131 Pulmonary 
surfactants, such as CUROSURF® (Chiesi Farmaceutici, SpA, 
Parma, Italy) are able to nonspecifically bind to CNT and, in 
turn, be able to alter the composition of the protein corona as 
a result of precoating and altered hydrophobic interactions.132 
It is believed that the protein corona decides the fate of the 
NP in vivo, and since the composition of the protein corona 
is dependent on the hydrophilicity of CNTs, the eventual 
fate can be controlled with adequate processing of CNTs. 
Even though precoating with polymers and surfactants, and 





rendering the CNT surface as hydrophilic, cannot completely 
abolish protein corona formation, it has the propensity to 
decrease and alter the protein profile that could enhance 
CNT’s in vivo biodistribution and biokinetics.
Surface property and charge





, and quartz sand, Sund et al117 identified that adsorbed 
plasma proteins, such as fibrinogen, complement proteins, 
Igs, and apolipoproteins, did not vary, and they covered NPs 
irrespective of their surface properties. However, the binding 
efficiency of these NPs to cell lysate proteins varied based 
on surface characteristics. This is attributable to plasma 
proteins having glycosylated residues not commonly encoun-
tered among cytoplasmic proteins. The formation of protein 
coronas around NPs might also likely be due to alterations 
in their surface properties due to the pH of the surrounding 
environment. TiO
2
 interacts with proteins more effectively at 
pH 6 compared to neutral and near-basic pH values.
Most functional groups have a net charge and, even though 
they can independently contribute to the interaction dynam-
ics with plasma proteins and macrophages, we will analyze 
them together in this section. Recent investigations using 
nanoshells have shown that positively charged particles have 
a higher rate of uptake by phagocytic cells in comparison to 
negatively charged and neutral particles.133 In another study, 
negatively charged PEG–single-walled carbon nanohorns 
displayed lower macrophage uptake.134 It is important to note 
that the density of the surface coating is equally important in 
determining cellular uptake.  Different NPs can demonstrate 
highly discordant behavior when internalization is purely 
analyzed from a charge-based perspective. For example, 
recently, in vivo intravital real-time multiphoton microscopy 
of the liver revealed that positively charged mesoporous silica 
NPs was primarily taken up by hepatocytes, and negatively 
charged particles were taken up by phagocytic Kupffer cells 
(Figure 5).96 Likewise, a study using polystyrene NPs showed 
that negatively charged particles had a higher internaliza-
tion rate into macrophages, and positively charged particles 
into monocytes.135 Highly charged surfaces, in comparison 
to neutral particles, attract complement factors. However, 
Liu et al136 demonstrated that complement factors are not 
activated in the presence of neutral and negatively charged 
particles. Patel et al,110 on the other hand, demonstrated that 
positively charged particles became negatively charged 
in serum after the opsonization process. Experiments on 
polystyrene particles functionalized with amine, hydroxyl, 
carboxyl, and sulfate groups have demonstrated that amine 
groups, along with hydroxyl groups, activate complement 
proteins C3 and C4.113 Also, experiments on thiolated NPs 
have revealed shorter plasma half-lives, up to 3 hours, and 
preferential uptake by spleen.137 Therefore, the design of 
“stealth” NPs should incorporate several parameters that 
are important in collectively rendering the NPs transparent 
to the phagocytic cells of the RES.
Strategies to shield CNTs
Many strategies that are used to coat CNTs for efficient 
in vivo functionality have erupted over the last decade 
 (Figure 4). While some studies have focused on the interac-
tion of these hybrid CNTs with cells such as macrophages, 
lung epithelia, skin fibroblasts, and varied tumor cells at the 
cellular level, others have looked at their pharmacokinet-
ics and biodistribution profiles in vivo.62,70,138–146 However, 
a majority of these strategies are focused at aiding the 
internalization of CNTs into their respective cell types for 
imaging and therapy. While this addresses the targeting com-
ponent of the CNT-based nanoagents, it avoids the issue of 
opsonization when the particles are introduced into biofluids. 
It is possible that some of these novel coatings could impart 
their requisite “stealth” character to the CNTs. This, how-
ever, is seldom practiced due to a variety of considerations. 
A holistic approach, whereby the manufactured hybrid CNT 
nanoagents are tested and validated both for targeting and 
long circulation times in vivo, will lead to better assessment 
and confidence in their potential.
The strategies used to shield the CNTs can be broadly 
divided into noncovalent and covalent (Figure 2). The 
noncovalent modality for shielding CNTs have been dem-
onstrated in order to improve blood circulation time and 
biodistribution.42,147 A hybrid construct made of lipid and 
PEG was used, where the lipid moiety interfaces with the 
CNT sidewall through hydrophobic interaction, and PEG 
affords improved biodistribution. The report suggests a stable 
interaction between the lipid moiety and the CNT surface 
throughout the study. This is important since dissociation of 
the lipid–PEG construct from the CNT will enable the ready 
adsorption of opsonins, along with various plasma proteins, 
for recognition and elimination by the RES pathway. How-
ever, in a recent study,148 it was shown that MWNTs pretreated 
with CUROSURF®, a pulmonary surfactant consisting pri-
marily of PLs, and incubated with blood plasma, underwent 
dynamic changes in the lipid coatings. The primary blood 
plasma lipids, such as cholesterol and triglycerides, appeared 
to bind to the MWNTs, and there was also a low association of 
phosphatidylserine (PS), one of the PLs from CUROSURF®. 





In a related study,138 it was demonstrated that SWNTs coated 
with PS were recognized by professional macrophages and 
internalized through the endocytotic pathway. However, there 
was no recognition or uptake of phosphatidylcholine-coated 
SWNTs by  macrophages. In apoptotic cells, PS is no longer 
restricted to the cytoplasmic side of the membrane and is 
exposed on the surface to the extracellular medium, thus 
enabling recognition by PS-specific receptors present on 
macrophages. Taking cues from such natural processes, one 
can envisage the development of artificial agents that exploit 
this machinery for effective in vivo roles. Can PLs devoid of 
PS be used as a potential “stealth” imparting moiety, provided 
their stability in an in vivo dynamic environment is reliable? 
Even though this concept is significantly compelling, it is 
early to conclude that MWNTs pretreated with lipids can 
be displaced by plasma lipids, and possibly even proteins, 
upon exposure to blood. This phenomenon is reminiscent 
of the Vroman effect, which originally described complex 
protein adsorption–desorption effects occurring on particle 
surfaces.149 Highly mobile proteins such as bovine serum 
albumin adsorbed on biopolymer surfaces were observed 
to be displaced by less mobile, but high-affinity, proteins 
such as fibrinogen. Besides the binding affinity and stability 
of the lipophilic interfacing moiety, it is also important to 
consider the hydrophilic interfacing group (PEG) that affords 
immunity to the CNTs against opsonins. For this, considering 
the high aspect ratio of CNTs and other rod-shaped NPs in 
general, length, density, and the conformational state of the 
polymer moiety plays a significant role in determining the 
stealth behavior of CNTs.
Liu et al42 demonstrated that increasing the length of the 
linear PEG chain from 2 kDa to 5 kDa increased the blood 
residence time from ∼1.2 hours to 5 hours. However, there 
was negligible improvement in the blood residence time 
when 7 kDa and 12 kDa PEG were used. When branched 
7 kDa PEG chains were used, a dramatic increase in the 
blood residence time of ∼15 hours was observed.150 Further 
studies carried out by Liu et al143 using different densities, 
ranging from 5%, 10%, 25%, 50%, and 100% with both 
2 kDa and 5 kDa PEG chains, brought about increasing 
blood circulation times, up to ∼12.8 hours for 10%–5kDa 
PEG to ∼21 hours for 100%–5kDa PEG. This suggests 
the effect of increasing linearity and density of polymer 
coating on the ability of hybrid CNT constructs to evade 
opsonins, thereby improving blood circulation times (Figure 
6). Improved density translates to lowering the unoccupied 
gaps on the CNT surface that could potentially serve as 
attachment sites for opsonins. The biodistribution profile of 
the respective PEG chains demonstrate predominant uptake 
by RES organs such as the liver, spleen, and bone marrow, 
more so for the linear PEG chains. Long-term fates of the 
linear PEG–SWNT constructs in the animals showed that 
the majority of them were excreted via the biliary pathway 
into the intestine, and eventually through feces. The authors 
also alluded to renal excretion among a small percentage of 
SWNTs that were below the glomerular excretion threshold 
(,50 nm) at 24 hours post-injection. Interestingly, there was 
significant accumulation of the long circulating constructs 
with half-lives .16 hours, 50%–5kDa PEG and 100%–5kDa 
PEG in the skin (∼29% ID/g), which is comparable to tumor 
uptake (∼23% ID/g). In contrast, there was relatively lower 
uptake of 10%–5kDa PEG with blood circulation times of 
∼12.8 hours in the skin (∼3% ID/g), as well as acceptable 
tumor uptake (∼15% ID/g).  Accumulation of ultra-long 
circulating PEG–SWNT in skin is intriguing and presents 
unusual challenges that could potentially interfere with 
the purported applications such as PT and PA imaging and 
therapy, where there is a high probability of interference 
from the accumulated dermal SWNT lying in the beam path. 
Therefore, it seems that a good balance of optimal circula-
tion times, tumor uptake, and low accumulation in the RES 
organs and skin by controlling the length and density of the 
polymer coating, will help in achieving a desirable outcome. 
However, these studies, have seemingly omitted evaluation 
of the biphasic pattern in plasma concentration profile of the 
hybrid adducts. Any injectable is eliminated from the blood 
through two phases: 1) an initial α-phase, where the injectable 
is rapidly distributed to the tissues from the blood, followed 
by a pseudo-equilibrium phase where the drug equilibrates 
between the blood and tissue compartments; and 2) a gradual 
β-phase, where the drug is slowly metabolized and excreted. 
This would be helpful in determining the relationship between 
the different phases and organ-specific uptake – tumor uptake 
in particular.
The pan European groups of Bianco et al14 and Kostarelos 
et al151 have spearheaded the biological characterization 
and pharmacokinetics of covalently functionalized CNTs 
(Figure 2). Ammonium-functionalized CNTs were generated, 
to which DTPA, a chelating molecule, was linked to enable 
the complexation of γ-emitting radiometals such as 111In.88 The 
research groups demonstrated that CNTs functionalized in 
this fashion underwent rapid renal  clearance, with preferential 
accumulation (∼20%) observed in muscle, skin, blood, and kid-
ney, 30 minutes post-injection. This fell to ,1% after 3 hours 
and ,0.7% after 24 hours. The blood circulation half-life 
was ∼3.5 hours. As seen with the noncovalently- functionalized 





CNTs, the blood circulation half-life was improved by increas-
ing the degree of functionalization through the introduction 
of acid-induced surface defects, to which additional DTPA 
molecules were linked.152 The initial blood half-life (t
1/2
) of 
the CNTs with a high degree of functionalization measured 
0.013 h−1, which demonstrates that the CNTs were distributed 
rapidly post-injection. The second phase blood half-life (t
1/2β) 
measured ∼7 hours. A similar study by Jain et al,8 employing 
99mTc-labeled carboxylated MWNTs with different degrees 
of functionalization up to ∼3.4 µmol/mg carboxyl density, 
was evaluated. MWNTs were subjected to oxidation by acids 
for 1 hour, 2 hours, 4 hours, and 6 hours. Higher degrees of 
agglomeration of the CNTs was seen in 1-hour- and 2-hour-
treated MWNTs, evident by the higher uptake and retention 
of these tubes, even after 24 hours, by the RES organs, such 
as the liver, spleen, and lungs. However, MWNTs oxidized 
for 4 hours and 6 hours, which also had considerable uptake 
by the RES organs, were slowly cleared in the span of 2–24 
hours. This confirms the predominant role of the degree of 
functionalization in improving the density of coverage over 
CNTs, thus effectively shielding the entire surface of the rod. 
In the past, density and branching of the shielding materials 
were shown to be the most important parameters for deter-
mining blood circulation (t
1/2β) and not length, chemistry, or 
architecture.
The ideal blood circulation half-life is application 
 dependent. For imaging, which requires the particles to accu-
mulate and achieve concentrations in the tissues followed by 
clearance, to produce adequate contrast, the optimum t
1/2
 is 2–6 
hours. In comparison, for therapeutic purposes, the optimal 
t
1/2
 is significantly longer to facilitate the repeated pooling of 
the particles in the tissue of interest. So far, the PEG-shielded 
CNT seems to be the polymer of choice for both imaging and 
therapeutics with its longer t
1/2
, which is in comparison to the 
∼7-hour t
1/2
 of covalently functionalized CNTs.  However, 
some recent reports have shown that PEG–SWNT hybrids 
elicit concentration- and surface  density-dependent cytotoxic-
ity in PC12 cells, caused by oxidative stress.153 Another report 
suggests that PL–PEG moieties are responsible for comple-
ment activation by CNT, triggering the lectin pathway.154 
Being one of the most extensively studied and reviewed 
molecules, PEG and its interactions with various particles 
are being elaborately characterized and reported. This augurs 
well for the biomedical community. Likewise, there is a 
need for alternative shielding agents that offer comparable, 
and sometimes better, efficacy after complexation with the 
particles. Pluronic surfactants such as F127 and F108 coated 
on MWNT have shown to afford better protection against 
nonspecific serum protein adsorption and anti-inflammatory 
processes.140,145 By effectively dispersing MWNTs, F108 
 passivates the CNT surface by forming a protective  brush-like 
layer that is able to prevent  profibrogenic responses in the 
macrophages through steric hindrance and, hence, have little 
cellular uptake. Another recently used strategy was to coat 
CNTs with a hydrophobic polystyrene polymer (50% w/w).155 
A considerable  enhancement in the dispersion of polystyrene 
coated CNTs and a subsequent reduction in internalization by 
macrophages was reported. We also reported a novel strategy 
to coat SWNTs with gold to create “golden nanotubes”, which 
benefits from the biocompatibility afforded by the surface 
gold plating and the complementary NIR absorption prop-
erties of the two materials.20 Highly specific localization of 
the golden nanotubes was observed in the lymphatic tissues 
60 minutes post-injection, with persistence of the significant 
PA/PT signal up to 5 hours, indicating good biodistribution 
and blood residence time. However, just as was noticed in 
PEG, there is an increased risk of adverse reaction against 
synthetic materials. Therefore, natural biopolymers such 
as saccharides, proteins, and nucleic acids can be deployed 
to shield the CNTs. Our group has reported shielding the 
SWNTs with dextran sulfate to prevent opsonization by 
uniformly coating the SWNT surface in a facile manner to 
minimize exposure of the hydrophobic sidewall of the SWNT 
to the external milieu.39 We have also demonstrated that there 
was minimal internalization of dextran–SWNT constructs by 
human macrophages after preincubating with opsonins, C3b, 
and Igs.25 Further, there is scope for employing biocompatible 
small molecules and proteins such as protein A and factor H 
complexes to SWNTs, to mimic common pathogens, such as 
Staphylococcus aureus, in evading the immune system.
Conclusion
CNTs represent a unique class of nanomaterials that have 
successfully bridged the gap between the biomedical and 
material sciences. A range of novel biomedical applications 
for CNTs has emerged in the last decade that showcases their 
potential for nanotheranostics. Several factors contribute to 
the stability and performance of CNTs in living systems, 
such as their biocompatibility, surface functionalization, 
biodistribution in tissues, and physicochemical characters 
including shape, size, and surface property, which were dis-
cussed in this review. Given their poor solubility in  aqueous 
solvents and in their native aggregated state, processing 
strategies, such as coating with shielding agents or  chemical 
treatment to modify the surface, is commonly practiced. 
Some of the widely used strategies include PEGylation, 





covalent functionalization with charged groups, and passiva-
tion through surfactants. Considerable improvement has been 
made in enhancing the blood circulation half-life and biodis-
tribution of the hybrid CNT constructs. To date, PEGylated 
CNTs have demonstrated the maximal blood residence time 
(∼21 hours) in comparison to covalently functionalized CNTs 
(∼7 hours). The two routes of excretion have been distinctly 
delineated based on the shielding strategies: noncovalent, 
namely through the hepato–biliary system; and covalent, 
through the renal system.
However, there still is a need for alternative shielding 
strategies that can provide not only stealth character to the 
CNTs, but also additional “smart” functionality. In our 
opinion, novel shielding agents should provide “smart” 
functionality to the CNT constructs in addition to their usual 
property of increasing blood residence time. Additional 
conjugation sites for improving the stoichiometry and the 
loading density of ligands, their modularity to incorporate 
a wide variety of functionalization strategies, and their pH 
and oxygen sensitivity, are some of the desired properties 
to render CNT-based theranostic nanoagents as multimodal 
and semiautonomous. There, however, are many pertinent 
health-related challenges that need to be overcome before 
approaching the subject of real clinical translation, such as 
persistence in the tissues, elimination, and the long-term 
after-effects of CNTs. Interestingly, there are encouraging 
reports towards realizing the complete degradation and 
elimination of CNTs in vitro and in cellulo. Emerging 
evidence shows that catalytic enzymes such as horseradish 
peroxidase are able to degrade carboxylated CNTs in the 
presence of hydrogen peroxide.100 This would, however, 
require that the CNTs are eventually localized in the acidic 
environments of the endosomes over prolonged periods of 
time for complete degradation. Kagan et al99 have reported 
biodegradation of CNTs in cellulo, occurring in neutrophils 
with the help of a neutrophil enzyme, MPO. When aspirated 
into the lungs of mice, the degraded CNTs failed to elicit 
an inflammatory response, suggesting the benign nature of 
the degraded byproducts. Perhaps future coating strategies 
can exploit this unique biodegradation pathway available 
in the form of polymorphonuclear cells, and the associated 
catalytic enzymes, through selective uptake. This, however, 
should ideally occur during the clearance phase of CNT 
biodistribution in order to prevent early sequestration, 
degradation, and excretion before its intended purpose is 
realized. If semi-autonomous multimodal theranostic CNT-
based nanoagents are envisaged, true hybrid constructs 
that take advantage of biological cues and natural systems 
should be designed. For example, the fates of foreign NPs 
and their hybrid nanoconstructs in vivo depend upon their 
physicobiochemical properties, including their size, shape, 
and surface chemistry. Some novel approaches have been 
reported to engineer NPs and their architectures with desir-
able size, shape, and functionality, including those based 
on the “nanotoolbox”-based programmable self-assembly 
approach developed by our group.2,3,156,157 The capability 
of modulating the geometric configurations and surface 
 characteristics suggests opportunities to overcome the 
hurdle, while considerably increasing blood circulation 
times as well as biocompatibility.128,129 There exist many 
biological particles, such as blood cells and pathogenic 
bacteria, that have evolved to evade macrophages by being 
transparent to the blood opsonins. Using lessons from 
nature, the design and construction of nanostructures with 
particular shapes and surface characteristics may permit 
us to avoid opsonization and premature clearance of 
nanotheranostics,2,3 enabling realization of NP-based thera-
nostics and their translation into clinical practice. Finally, as 
the technology progresses, appealing new directions would 
arise that could transform the field of nanomedicine beyond 
those described in this review.
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